ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism
Phase 2
- Conditions
- Cancer-associated ThrombosisEsophageal CancerStomach CancerDuodenal CancerEsophagogastric Junction CancerMalignant Gastrointestinal Stromal TumorAmpulla of Vater CancerHepatocellular CarcinomaPancreatic CancerBiliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)
- Interventions
- First Posted Date
- 2017-05-04
- Last Posted Date
- 2020-01-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 176
- Registration Number
- NCT03139487
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease
- First Posted Date
- 2017-04-13
- Last Posted Date
- 2020-12-14
- Lead Sponsor
- Asan Foundation
- Target Recruit Count
- 12
- Registration Number
- NCT03112096
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma
Phase 2
Completed
- Conditions
- Biliary Tract CancerAdjuvant ChemotherapyCapecitabineGemcitabineCholangiocarcinomaCisplatin
- Interventions
- First Posted Date
- 2017-03-14
- Last Posted Date
- 2022-12-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 101
- Registration Number
- NCT03079427
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors
Phase 2
Completed
- Conditions
- TemozolomideCapecitabineNeuroendocrine CarcinomaNeuroendocrine Tumors
- Interventions
- Drug: TEMCAP
- First Posted Date
- 2017-03-14
- Last Posted Date
- 2022-12-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 31
- Registration Number
- NCT03079440
- Locations
- 🇰🇷
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Development of Distress Management Algorithms Using Mobile Device Based Health Logs in Breast Cancer Survivors
Not Applicable
Completed
- Conditions
- Quality of LifeBreast Cancer
- Interventions
- Device: Wearable device (Fitbit Charge HR® or Fitbit Alta ®)
- First Posted Date
- 2017-03-08
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 160
- Registration Number
- NCT03072966
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Korea, Republic of
Safety and Efficacy of an Early Rehabilitation Program in Surgical Intensive Care Unit
Not Applicable
Completed
- Conditions
- ICU-acquired Weakness
- Interventions
- Behavioral: Early rehabilitation program
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2017-02-16
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 131
- Registration Number
- NCT03055949
Blood Flow Change After Free Flap Surgery in Diabetic Patients
Completed
- Conditions
- Diabetes
- First Posted Date
- 2017-01-23
- Last Posted Date
- 2018-11-30
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 44
- Registration Number
- NCT03027219
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Incidence and Risk Factors for Delirium in Severely Injured Patients
Completed
- Conditions
- DeliriumTraumaIntensive Care Unit Syndrome
- First Posted Date
- 2017-01-18
- Last Posted Date
- 2017-01-19
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 179
- Registration Number
- NCT03023839
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy
- First Posted Date
- 2016-12-30
- Last Posted Date
- 2016-12-30
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT03006081
- Locations
- 🇰🇷
Asan medical center, Olympicro 43 gil 88, Seoul, Korea, Republic of
Neurological Outcomes After In-Hospital Cardiac Arrest
Completed
- Conditions
- Inhospital Cardiac Arrest
- Interventions
- Other: No intervention
- First Posted Date
- 2016-12-30
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 322
- Registration Number
- NCT03006484
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of